OSAKA--Nobel laureate Tasuku Honjo’s long-running dispute with Osaka-based Ono Pharmaceutical Co. for royalties following his discovery of the anti-cancer drug Opdivo has finally led to a settlement in which the pharmaceutical giant will pay him 5 billion yen ($44 million) in compensation. [Read More]

No reproduction or republication without written permission.